The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis

Abstract

CD44 has recently been reported as a cancer stem cell marker in ovarian cancer. However, the clinicopathological and prognostic value of this marker in ovarian cancer remains controversial; Here, we aimed to investigate the correlation between CD44 expression and the clinicopathological features or survival of ovarian cancer patients. An extensive… (More)
DOI: 10.1186/s12935-016-0376-4

Topics

11 Figures and Tables

Cite this paper

@inproceedings{Lin2016ThePR, title={The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis}, author={Jiaying Lin and Ding Ding}, booktitle={Cancer Cell International}, year={2016} }